FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986403799> ?p ?o ?g. }

• W2986403799 endingPage "1080" @default.
• W2986403799 startingPage "1067" @default.
• W2986403799 abstract "Diabetes Prevention Programs (DPPs) comprising intensive lifestyle interventions may delay or even prevent the onset of type 2 diabetes in people with pre-diabetes. However, engagement with DPPs is variable with session times and transportation being reported amongst barriers; this may be addressed by community pharmacy (CP) involvement given its recognition for accessibility. To explore factors influencing engagement with the National Health Service (NHS) DPP and the role of CP in diabetes prevention. Nine hundred and sixty-two questionnaires were posted to people with pre-diabetes identified from five general practices in Norfolk, England between November 2017 and May 2018. Follow-up semi-structured interviews (n = 10) and a focus group (n = 6) were conducted with a sample of questionnaire respondents. Questionnaire data were analysed quantitatively using SPSS and qualitative data analysed inductively using thematic analysis. Themes relating to engagement and the role of CP in pre-diabetes were further analysed using the COM-B model of behaviour change. A total of 181 (18.8%) questionnaire responses were received, a quarter of whom reported to have either dropped out or declined attending the national DPP. DPP engagers were more likely to report the program location and session times as convenient. Community pharmacy was perceived as an acceptable setting for delivering diabetes prevention services (DPS) and a preferable alternative for regular pharmacy users and people with work and social commitments. Participants felt that opportunity to engage with CP DPS is enhanced by its accessibility and flexibility in making appointments. Knowledge about the DPS provided in CP and previous experience with CP services were central influences of capability and motivation to engage respectively. This research outlines factors that could influence engagement with community pharmacy-based DPS and provides evidence to inform intervention development. Further research would be required to determine the feasibility and cost-effectiveness of such interventions." @default.
• W2986403799 created "2019-11-22" @default.
• W2986403799 creator A5001453613 @default.
• W2986403799 creator A5012676869 @default.
• W2986403799 creator A5037943130 @default.
• W2986403799 creator A5050825045 @default.
• W2986403799 creator A5077844351 @default.
• W2986403799 date "2020-08-01" @default.
• W2986403799 modified "2023-10-11" @default.
• W2986403799 title "The community pharmacy setting for diabetes prevention: A mixed methods study in people with ‘pre-diabetes’" @default.
• W2986403799 cites W1524829680 @default.
• W2986403799 cites W1539317018 @default.
• W2986403799 cites W1575662529 @default.
• W2986403799 cites W1878781068 @default.
• W2986403799 cites W1929748564 @default.
• W2986403799 cites W1974372030 @default.
• W2986403799 cites W1979290264 @default.
• W2986403799 cites W2003598964 @default.
• W2986403799 cites W2006625394 @default.
• W2986403799 cites W2014991138 @default.
• W2986403799 cites W2026170963 @default.
• W2986403799 cites W2035632299 @default.
• W2986403799 cites W2081583008 @default.
• W2986403799 cites W2095645712 @default.
• W2986403799 cites W2097036411 @default.
• W2986403799 cites W2110444486 @default.
• W2986403799 cites W2127599485 @default.
• W2986403799 cites W2129374379 @default.
• W2986403799 cites W2136608905 @default.
• W2986403799 cites W2145688328 @default.
• W2986403799 cites W2152434176 @default.
• W2986403799 cites W2152439037 @default.
• W2986403799 cites W2159179396 @default.
• W2986403799 cites W2214510180 @default.
• W2986403799 cites W2484225648 @default.
• W2986403799 cites W2520330416 @default.
• W2986403799 cites W2613516574 @default.
• W2986403799 cites W2620281395 @default.
• W2986403799 cites W2754799758 @default.
• W2986403799 cites W2767337822 @default.
• W2986403799 cites W2771402750 @default.
• W2986403799 cites W2778111288 @default.
• W2986403799 cites W2789577829 @default.
• W2986403799 cites W2792647339 @default.
• W2986403799 cites W2887297174 @default.
• W2986403799 cites W2958194763 @default.
• W2986403799 doi "https://doi.org/10.1016/j.sapharm.2019.11.001" @default.
• W2986403799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31734102" @default.
• W2986403799 hasPublicationYear "2020" @default.
• W2986403799 type Work @default.
• W2986403799 sameAs 2986403799 @default.
• W2986403799 citedByCount "9" @default.
• W2986403799 countsByYear W29864037992021 @default.
• W2986403799 countsByYear W29864037992022 @default.
• W2986403799 countsByYear W29864037992023 @default.
• W2986403799 crossrefType "journal-article" @default.
• W2986403799 hasAuthorship W2986403799A5001453613 @default.
• W2986403799 hasAuthorship W2986403799A5012676869 @default.
• W2986403799 hasAuthorship W2986403799A5037943130 @default.
• W2986403799 hasAuthorship W2986403799A5050825045 @default.
• W2986403799 hasAuthorship W2986403799A5077844351 @default.
• W2986403799 hasBestOaLocation W29864037992 @default.
• W2986403799 hasConcept C104863432 @default.
• W2986403799 hasConcept C134018914 @default.
• W2986403799 hasConcept C144024400 @default.
• W2986403799 hasConcept C144133560 @default.
• W2986403799 hasConcept C15744967 @default.
• W2986403799 hasConcept C159110408 @default.
• W2986403799 hasConcept C162853370 @default.
• W2986403799 hasConcept C166957645 @default.
• W2986403799 hasConcept C190248442 @default.
• W2986403799 hasConcept C27415008 @default.
• W2986403799 hasConcept C2994493120 @default.
• W2986403799 hasConcept C36289849 @default.
• W2986403799 hasConcept C512399662 @default.
• W2986403799 hasConcept C555293320 @default.
• W2986403799 hasConcept C56995899 @default.
• W2986403799 hasConcept C71924100 @default.
• W2986403799 hasConcept C74196892 @default.
• W2986403799 hasConcept C74909509 @default.
• W2986403799 hasConcept C85079727 @default.
• W2986403799 hasConcept C95457728 @default.
• W2986403799 hasConceptScore W2986403799C104863432 @default.
• W2986403799 hasConceptScore W2986403799C134018914 @default.
• W2986403799 hasConceptScore W2986403799C144024400 @default.
• W2986403799 hasConceptScore W2986403799C144133560 @default.
• W2986403799 hasConceptScore W2986403799C15744967 @default.
• W2986403799 hasConceptScore W2986403799C159110408 @default.
• W2986403799 hasConceptScore W2986403799C162853370 @default.
• W2986403799 hasConceptScore W2986403799C166957645 @default.
• W2986403799 hasConceptScore W2986403799C190248442 @default.
• W2986403799 hasConceptScore W2986403799C27415008 @default.
• W2986403799 hasConceptScore W2986403799C2994493120 @default.
• W2986403799 hasConceptScore W2986403799C36289849 @default.
• W2986403799 hasConceptScore W2986403799C512399662 @default.
• W2986403799 hasConceptScore W2986403799C555293320 @default.
• W2986403799 hasConceptScore W2986403799C56995899 @default.
• W2986403799 hasConceptScore W2986403799C71924100 @default.

• next